| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
|
34,744 |
3,050 |
$3.72M |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
15,737 |
1,003 |
$28K |
| A4657 |
Syringe, with or without needle, each |
4,014 |
1,667 |
$367.50 |
| 82728 |
|
806 |
742 |
$0.00 |
| J1270 |
Injection, doxercalciferol, 1 mcg |
6,774 |
649 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
386 |
308 |
$0.00 |
| 83550 |
|
810 |
747 |
$0.00 |
| J0604 |
Cinacalcet, oral, 1 mg, (for esrd on dialysis) |
473 |
63 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
29 |
28 |
$0.00 |
| 90674 |
|
16 |
15 |
$0.00 |
| 85041 |
|
914 |
850 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
2,680 |
662 |
$0.00 |
| 85048 |
|
913 |
849 |
$0.00 |
| 83540 |
|
817 |
753 |
$0.00 |
| 83970 |
|
793 |
740 |
$0.00 |
| 85045 |
|
268 |
256 |
$0.00 |
| 82108 |
|
86 |
77 |
$0.00 |